aarti drugs

19,000 to 1,73,000 shareholders in one year — what happened next wasn’t pretty

February 19, 2026

We all look at financial data like Sales, PAT, ROE, Debt equity ratio, cash flows, etc. However, a lot of times, one can get substantial insights from other data points like Insider Buying, Shareholding Pattern, No. of shareholders data, etc. In this post, we will look at Aarti Drugs’ no. of shareholders data and see if can find some interesting insights.   Before that: Here’s the list of new recommendations released in last few weeks: For Insider Bets members – On 22nd Jan’26, we released our New stock…

Read More

[Stock idea] – Aarti Drugs…notes for a leading pharma API company

March 18, 2023

Hello Sir,Hope you are doing well.Remember, in late 2020, Pharma API companies were the darling of the market. Most are down 50-60% from their highs and in downtrend. Their high margins of FY 20-21 didn’t sustain.It seems like earnings may have bottomed out and some of them seem to be available at reasonable valuations from a 3-4 years investment perspective.Aarti Drugs is a major player in the pharma API segment and has been a very lucky stock for us.We have recommended…

Read More

[Stock Idea] – Aarti Drugs…notes from the Q1 FY 23 concall

August 15, 2022

Hello Sir,Hope you are doing well.Remember, in late 2020, Pharma API companies were the darling of the market. Most are down 40-50% from their highs and in downtrend. Their high margins of FY 20-21 didn’t sustain. Some of them will soon be available at reasonable valuations on long term mean margins and that will be a good time to invest.Aarti Drugs is a major player in the pharma API segment and has been a very lucky stock for us. We recommended…

Read More